Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 11, 2017
Frontline defenders: goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and diseaseJoannie M Allaire, Vijay Morampudi, Shauna M Crowley, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 5, 2015
Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitisNatasha R Ryz, Arion Lochner, Kirandeep Bhullar, et al.
The American Journal of Pathology|June 7, 2011
SHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosisKeith W McLarren, Alexandra E Cole, Shelley B Weisser, et al.
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatmentUpton Allen, Caroline Alfieri, Jutta Preiksaitis, et al.
Vaccines|June 27, 2025
Durability of Antibody Responses to SARS-CoV-2 Vaccination over 12 Months in Pediatric Inflammatory Bowel DiseaseSally J Lawrence, Marina Viñeta Paramo, Frederic Reicherz, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 16, 2022
Highly Sensitive, Flow Cytometry-Based Measurement of Intestinal Permeability in Models of Experimental ColitisKevin Tsai, Caixia Ma, Xiao Han, et al.
Inflammatory Bowel Diseases|January 27, 2026
Biopsy-derived colonoid air-liquid interface monolayers reveal persistent mucosal defects in ulcerative colitis patientsAshley Gilliland, Yan Chen, Irvin Ng, et al.
Frontiers in Immunology|May 16, 2025
Crosstalk with infant-derived Th17 cells, as well as exposure to IL-22 promotes maturation of intestinal epithelial cells in an enteroid modelZohreh Sharafian, Paula T Littlejohn, Christina Michalski, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2025
Development of novel GI-centric prostaglandin E2 receptor type 4 (EP4) agonist prodrugs as treatment for ulcerative colitis and other intestinal inflammatory diseasesSrinivas Kantham, Hongbing Yu, Christophe R Cantelli, et al.
Pageof 15